Competitor News, Fundraising/IPO

BC Platforms Announces USD 20 Million Growth Financing led by Jolt Capital

Investment to Underpin Position as Europe’s Leading Real World Data Provider and enabler of Personalized Precision Medicine ZURICH, Nov. 8, 2022 /PRNewswire/ — BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced it has closed a CHF 20 million (approx. USD 20 million) financing round. This growth equity financing was led by new investor Jolt…

Competitor News, M&A

Anumana Acquires NeuTrace, Establishing a Comprehensive Electrophysiology Deep-Learning Development Platform and Product Pipeline

November 07, 2022 02:31 PM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, an AI-driven health technology company and portfolio company of nference, announced today it has acquired NeuTrace, a medical technology company advancing novel in-procedure AI applications for electrophysiology (EP). The acquisition includes the NeuTrace EP Data Biome platform and a portfolio…

Industry News

Real-world data: a brief review of the methods, applications, challenges and opportunities

Abstract Background The increased adoption of the internet, social media, wearable devices, e-health services, and other technology-driven services in medicine and healthcare has led to the rapid generation of various types of digital data, providing a valuable data source beyond the confines of traditional clinical trials, epidemiological studies, and lab-based…

Competitor News, Europe, International, RWE Study

Flatiron Health Announces Research to be Presented at International Society for Pharmacoeconomics and Outcomes Research Europe 2022 Annual Meeting

November 04, 2022 09:30 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Flatiron Health is pleased to announce their attendance and presence at the ISPOR, The Professional Society for Health Economics and Outcomes Research Europe 2022 Conference, held in Vienna, Austria this year. A total of 7 presentations will be presented by Flatiron, including…

Competitor News, Product Updates

Tempus Launches First Cardiology Prospective Study for Its AI-Enabled Predictive Tests

In collaboration with iRhythm, Tempus is studying its predictive, AI-enabled algorithmic tests via a network of researchers to determine the impact of detecting patients at increased risk of developing cardiovascular disease November 03, 2022 09:15 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today…